Klamroth R - Search Results

1

Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study.

Krause M, Sonntag B, Klamroth R, Heinecke A, Scholz C, Langer C, Scharrer I, Greb RR, von Eckardstein A, Nowak-Göttl U. Krause M, et al. Among authors: klamroth r. Thromb Haemost. 2005 May;93(5):867-71. doi: 10.1160/TH04-08-0519. Thromb Haemost. 2005. PMID: 15886801

2

Addendum zur S2k-Leitlinie Gastrointestinale Blutungen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS).

Götz M, Biecker E, Dechêne A, Schilling D, Zipprich A, Trebicka J; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (federführend); Deutsche Morbus Crohn und Colitis ulcerosa Vereinigung (DCCV); Deutsche Röntgengesellschaft (DRG); Deutsche Gesellschaft für interventionelle Radiologie (DeGiR); Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV) und Chirurgische Arbeitsgemeinschaft für Endoskopie und Sonografie (CAES) der DGAV; Deutsche Gesellschaft für Internistische Intensivmedizin (DGIIN); Deutsche Gesellschaft für Innere Medizin (DGIM); Deutsche Gesellschaft für Kardiologie (DGK); Akademie für Ethik in der Medizin (AEM); Gesellschaft für Thrombose und Hämostaseforschung (GTH); Collaborators. Götz M, et al. Z Gastroenterol. 2022 Jul;60(7):1139-1145. doi: 10.1055/a-1788-3501. Epub 2022 Jul 11. Z Gastroenterol. 2022. PMID: 35817045 Free article. German. No abstract available.

3

Prevalence of COVID-19 related hospitalizations and mortality in adults aged ≥40 years with haemophilia: A survey from Europe.

Hermans C, Astermark J, Carvalho M, Dolan G, d'Oiron R, Fontana P, Holme PA, Kenet G, Klamroth R, Mancuso ME, Marquardt N, Nunez R, Katsarou O, Pabinger-Fasching I, Quintavalle G, Rodgers R, van der Valk P, Windyga J, Jimenez Yuste V, Preložnik Zupan I. Hermans C, et al. Among authors: klamroth r. Haemophilia. 2023 May;29(3):913-916. doi: 10.1111/hae.14761. Epub 2023 Feb 18. Haemophilia. 2023. PMID: 36802089 No abstract available.

4

Real-world evidence on efmoroctocog alfa in patients with haemophilia A: A systematic literature review of treatment experience in Europe.

Blatný J, Nielsen EM, Reitzel SB, McMillan AC, Danø A, Bystrická L, Kragh N, Klamroth R. Blatný J, et al. Among authors: klamroth r. Haemophilia. 2023 Jul;29(4):963-974. doi: 10.1111/hae.14797. Epub 2023 May 27. Haemophilia. 2023. PMID: 37243934 Review.

5

Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials.

Mancuso ME, Eriksson D, Falk A, Hakimi Z, Wojciechowski P, Wdowiak M, Klamroth R. Mancuso ME, et al. Among authors: klamroth r. J Blood Med. 2023 Jul 27;14:427-434. doi: 10.2147/JBM.S389094. eCollection 2023. J Blood Med. 2023. PMID: 37534261 Free PMC article.

6

[Acquired bleeding disorders - diagnostic approach].

Klamroth R. Klamroth R. Internist (Berl). 2014 May;55(5):514-20. doi: 10.1007/s00108-013-3421-6. Internist (Berl). 2014. PMID: 24715274 Review. German.

7

[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group].

Dempfle CE, Gulba D, Kirchmaier CM, Klamroth R, Korte W, Lorenz R, Peck-Radosavljevic M, Veldman A, Zotz RB. Dempfle CE, et al. Among authors: klamroth r. Med Klin (Munich). 2007 Jan 15;102(1):70-81. doi: 10.1007/s00063-007-1012-9. Med Klin (Munich). 2007. PMID: 17221356 German.

8

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A.

von Drygalski A, Chowdary P, Kulkarni R, Susen S, Konkle BA, Oldenburg J, Matino D, Klamroth R, Weyand AC, Jimenez-Yuste V, Nogami K, Poloskey S, Winding B, Willemze A, Knobe K; XTEND-1 Trial Group. von Drygalski A, et al. Among authors: klamroth r. N Engl J Med. 2023 Jan 26;388(4):310-318. doi: 10.1056/NEJMoa2209226. N Engl J Med. 2023. PMID: 36720133 Clinical Trial.

9

[Operation and hemophilia : no problem with good interdisciplinary management].

Klamroth R. Klamroth R. Anaesthesist. 2014 Jan;63(1):5. doi: 10.1007/s00101-013-2271-x. Anaesthesist. 2014. PMID: 24399371 German. No abstract available.

10

Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis.

Astermark J, Buckner TW, Frenzel L, Hatswell AJ, You X, Liu H, Goodman E, Santos S, Hawes C, Hinds D, Klamroth R. Astermark J, et al. Among authors: klamroth r. Haemophilia. 2023 Jul;29(4):1087-1094. doi: 10.1111/hae.14818. Epub 2023 Jun 22. Haemophilia. 2023. PMID: 37347645

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters